Ernexa Therapeutics (ERNA) Return on Equity [ROE] (2011 - 2026)
Ernexa Therapeutics (ERNA) posted Return on Equity [ROE] of -243.70% for Q2 2026, up 2.24 percentage points from the prior quarter.
Powered by 
Analysis
Ernexa Therapeutics (ERNA) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Ernexa Therapeutics' Return on Equity [ROE] came in at -686.69%, up 1577.62 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of -602.89 percentage points (FY2020 to FY2025).
- In prior years, Ernexa Therapeutics' Return on Equity [ROE] was -2264.31% in FY2024 (-1962.11 pp), -302.20% in FY2023 (-171.50 pp), -130.70% in FY2022 (+608.36 pp) and -739.07% in FY2021 (-655.27 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q1 2023.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q1 2023, with a gain of 328.03 percentage points; the weakest was Q2 2022, with a drop of 582.38 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -245.94% (Q1 2026), -471.71% (Q4 2025) and -457.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Ernexa Therapeutics | 3.46 Mn | 3.46 Mn | - | -243.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -243.70% |
| Mar 31, 2026 | -245.94% |
| Dec 31, 2025 | -471.71% |
| Sep 30, 2025 | -457.70% |
| Dec 31, 2023 | -747.82% |
| Sep 30, 2023 | -538.61% |
| Jun 30, 2023 | -386.43% |
| Mar 31, 2023 | -211.62% |
| Dec 31, 2022 | -234.97% |
| Sep 30, 2022 | -256.35% |
| Jun 30, 2022 | -678.79% |
| Mar 31, 2022 | -539.65% |
| Dec 31, 2021 | -437.19% |
| Sep 30, 2021 | -275.08% |
| Jun 30, 2021 | -96.40% |
| Mar 31, 2021 | -227.09% |
| Dec 31, 2020 | -83.66% |
| Sep 30, 2020 | -55.86% |
| Jun 30, 2020 | -46.89% |
| Mar 31, 2020 | -31.40% |
API Access
Ernexa Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ERNA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ERNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ERNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();